• Aucun résultat trouvé

A One Health Framework for Estimating the Economic Costs of Zoonotic Diseases on Society

N/A
N/A
Protected

Academic year: 2021

Partager "A One Health Framework for Estimating the Economic Costs of Zoonotic Diseases on Society"

Copied!
13
0
0

Texte intégral

Loading

Figure

Figure 1. Modified risk analysis framework to enhance reduction of zoonotic disease burden.
Figure 2. Flow chart of dog–human rabies transmission (Zinsstag et al. 2009b, with permission).
Figure 3. Costs and benefits of Brucellosis control in Mongolia (Roth et al. 2003). Intervention cost (black), public health benefits (oblique lines), private health benefits (vertical lines), reduced household income loss (horizontal lines), agricultural

Références

Documents relatifs

Due to the anthropogenic nature of drivers of EZDs (increased human population, globalization, climate change) changes require government-level strategies that are integrated

CAZCOM will (1) develop molecular biology technical capacities by creating a molecular platform, training technical staff and establishing technical private/public

New research questions are emerging, which require the contribution of ecology and human and social science: for example, the role of the environment on health,

The cost of the control of additional risk generated by including NPs in the process can then be estimated by combining different costs, from that due to additional protection

Methods: A Markov model simulated chronic hepatitis C (CHC) prevalence, incidence of events, quality adjusted life years (QALYs), costs and incremental cost-effectiveness ratio

 Zaı¨re ebola virus (ZEBOV): in Gabon, ZEBOV outbreaks occurred in 1994, 1996, 1997 and 2001; 29 primary human cases were generally contaminated by direct contact with.. albopictu

Results presented in this study conftrm high animal prevalence of both tuberculosis and brucellosis, and surveys carried out in the human population concluded that the

The hierarchical co-primary objectives of this study were, first, to assess if sedation with dexmedetomidine (higher doses and/or longer duration than approved) is as good as